Showing results (401-410 of 461) with videos related to
Sort By:
Pageof 47
International Journal of Cancer|October 16, 1999
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphyW A Breeman, M De Jong, B F Bernard, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expressionA Durandy, C Hivroz, F Mazerolles, et al.La Revue De Medecine Interne|April 19, 2011
[Recurrent pericarditis revealing a systemic sarcoidosis]A-I Bocoum, A Daumas, S Cammilleri, et al.Clinical Immunology (Orlando, Fla.)|March 27, 2012
Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressorsPhilomena Kamya, Benjamin Tallon, Carlos Melendez-Pena, et al.Journal of Virology|September 29, 2021
Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV InfectionLauren Nagel, Sanket Kant, Christopher Leeks, et al.International Journal of Cancer|May 8, 2001
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapyM de Jong, W A Breeman, B F Bernard, et al.Plos One|November 28, 2012
Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptidesMehrnoosh Doroudchi, Oleg Yegorov, Tom Baumgartner, et al.Viral Immunology|June 15, 2011
Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA allelesYoav Peretz, Olivia Marra, Réjean Thomas, et al.Viruses|May 31, 2019
Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected IndividualsSanket Kant, Ningyu Zhang, Jean-Pierre Routy, et al.International Journal of Cancer|February 10, 1998
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapyM De Jong, W H Bakker, W A Breeman, et al.Pageof 47